10x Genomics Inc - Class A

TXG

$89.64

-40.3% last 12 months

Market Cap

$9.6 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$104.69 - $208.99

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

-21.08x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $9.6 Billion
Enterprise Value $9 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return -40.3%
52-Week High $208.99
52-Week Low $104.69
Beta 1.61
Outstanding Shares 91.6 Million
Avg 30 Day Volume 756 Thousand

Valuation

P/E Ratio -21.08
PEG 28.52
Earnings per Share -$4.17
Price to Sales Ratio 17.93
Price to Book Ratio 11.21
Revenue to Enterprise Value 19.6
EBIT to Enterprise Value -230.2
Total Debt to Enterprise Value 0.0
Debt to Equity 0.0

Profitability

Revenue $459 Million
Gross Profit $394 Million
EBIT -$39.1 Million
Net Income -$455 Million
Profit Margin -99.17%
Quarterly Earnings Growth (YoY) -73.9%
Return on Equity -56.9%
Return on Assets -45.97%
Return on Invested Capital -4.39%

Insider trades

No purchases

35,987 shares sold (21 transactions)

No purchases

36,125 shares sold (19 transactions)

No purchases

33,292 shares sold (11 transactions)

No purchases

3,532 shares sold (2 transactions)

Q2 2021 Q3 2021 Q4 2021 Q1 2022

About 10x Genomics Inc - Class A

CEO: Serge Saxonov

Industry: Testing Laboratories

Similar stocks

NovoCure Ltd
NovoCure Ltd
Novavax, Inc.
Novavax, Inc.
Organovo Holdings Inc
Organovo Holdings Inc
Orchard Therapeutics plc - ADR
Orchard Therapeutics plc - ADR

News